Synergistic Hepatic Disease Treatment System

A novel system integrating patented compositions for treating hepatic diseases and disorders with advanced technologies such as AI, IoT, blockchain, and new materials to provide personalized, real-time treatment and monitoring.

The original patent disclosed compositions and methods for treating hepatic diseases and disorders, but it had limitations in terms of personalization, real-time monitoring, and adaptability. The new inventive concept addresses these limitations by integrating the patented compositions with cutting-edge technologies to provide a more effective and efficient treatment system.

The new system comprises a pharmaceutical composition according to claim 1, a wearable device configured to monitor the patient's health metrics, and a machine learning algorithm that analyzes the health metrics and adjusts the pharmaceutical composition in real-time. Additionally, the system may include a blockchain-based platform for analyzing a patient's genetic profile and medical history, IoT-enabled devices for generating a customized treatment plan, and a nanoparticle-based delivery system that targets the liver. The system may also incorporate a non-invasive diagnostic device that uses AI-powered imaging to detect liver damage, and a predictive model of treatment outcomes using a blockchain-based platform.

The new claims introduce a synergistic combination of the patented compositions with advanced technologies, providing a novel and non-obvious solution for treating hepatic diseases and disorders. The integration of these technologies enables real-time monitoring, personalization, and adaptability, which are not possible with the original patent alone.

Alternative embodiments of the inventive concept may include different types of wearable devices, blockchain-based platforms, or IoT-enabled devices. The system may also be adapted for use in different medical settings, such as hospitals or clinics, or for use in conjunction with other treatment modalities.

The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of personalized medicine and precision health. The system may be marketed as a comprehensive solution for treating hepatic diseases and disorders, offering improved treatment outcomes and reduced healthcare costs.